Safety, tolerability, and pharmacokinetics of the anti-IGF-1R monoclonal antibody figitumumab in patients with refractory adrenocortical carcinoma (Q24607285)

From Wikidata

Jump to navigation Jump to search

scientific article

Language	Label	Description	Also known as
English	Safety, tolerability, and pharmacokinetics of the anti-IGF-1R monoclonal antibody figitumumab in patients with refractory adrenocortical carcinoma	scientific article

Statements

scholarly article

0 references

Safety, tolerability, and pharmacokinetics of the anti-IGF-1R monoclonal antibody figitumumab in patients with refractory adrenocortical carcinoma (English)

0 references

0 references

pharmacokinetics

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

adrenocortical carcinoma

1 reference

based on heuristic

inferred from title

monoclonal antibody

1 reference

based on heuristic

inferred from title

author name string

Paul Haluska

1

0 references

Frank Worden

2

0 references

David Olmos

3

0 references

Donghua Yin

4

0 references

David Schteingart

5

0 references

Gretchen N Batzel

6

0 references

M Luisa Paccagnella

7

0 references

Johann S de Bono

8

0 references

Antonio Gualberto

9

0 references

Gary D Hammer

10

0 references

language of work or name

0 references

publication date

March 2010

0 references

Cancer Chemotherapy and Pharmacology

0 references

65

0 references

4

0 references

765-73

0 references

Adjuvant mitotane treatment for adrenocortical carcinoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2875253

7 April 2017

Preclinical targeting of the type I insulin-like growth factor receptor in adrenocortical carcinoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2875253

27 September 2017

Insulin-like growth factor-I receptor signaling blockade combined with radiation

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2875253

27 September 2017

The role of the IGF system in cancer growth and metastasis: overview and recent insights

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2875253

27 September 2017

IGF-I mediated survival pathways in normal and malignant cells

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2875253

27 September 2017

Emerging treatment strategies for adrenocortical carcinoma: a new hope.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2875253

27 September 2017

Epidermal growth factor receptor/HER2/insulin-like growth factor receptor signalling and oestrogen receptor activity in clinical breast cancer.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2875253

27 September 2017

Insulin-like growth factor-I receptor signaling in tamoxifen-resistant breast cancer: a supporting role to the epidermal growth factor receptor.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2875253

27 September 2017

Insulin-like growth factor-I decreased etoposide-induced apoptosis in glioma cells by increasing bcl-2 expression and decreasing CPP32 activity.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2875253

27 September 2017

The role of the insulin-like growth factor system in colorectal cancer: review of current knowledge

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2875253

27 September 2017

Insulin-like growth factors and neoplasia.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2875253

27 September 2017

A chimeric humanized single-chain antibody against the type I insulin-like growth factor (IGF) receptor renders breast cancer cells refractory to the mitogenic effects of IGF-I.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2875253

27 September 2017

Distinct transcriptional profiles of adrenocortical tumors uncovered by DNA microarray analysis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2875253

27 September 2017

Effect of insulin-like growth factor II on protecting myoblast cells against cisplatin-induced apoptosis through p70 S6 kinase pathway

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2875253

27 September 2017

Adrenocortical carcinoma: clinical and laboratory observations

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2875253

27 September 2017

Hypoglycemic effect of insulin-like growth factor-1 in mice lacking insulin receptors

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2875253

27 September 2017

Structure-function relationship of the insulin-like growth factor-I receptor tyrosine kinase

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2875253

30 May 2018

Phase II study of the anti-insulin-like growth factor type 1 receptor antibody CP-751,871 in combination with paclitaxel and carboplatin in previously untreated, locally advanced, or metastatic non-small-cell lung cancer.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2875253

28 November 2018

Phase I, pharmacokinetic and pharmacodynamic study of the anti-insulinlike growth factor type 1 Receptor monoclonal antibody CP-751,871 in patients with multiple myeloma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2875253

28 November 2018

Phase I dose escalation study of the anti insulin-like growth factor-I receptor monoclonal antibody CP-751,871 in patients with refractory solid tumors

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2875253

28 November 2018

Expression profiling of adrenocortical neoplasms suggests a molecular signature of malignancy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2875253

28 November 2018

Combination therapy enhances the inhibition of tumor growth with the fully human anti-type 1 insulin-like growth factor receptor monoclonal antibody CP-751,871.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2875253

28 November 2018

Co-targeting HER2/ErbB2 and insulin-like growth factor-1 receptors causes synergistic inhibition of growth in HER2-overexpressing breast cancer cells

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2875253

28 November 2018

Functional insulin receptors on human epithelial ovarian carcinoma cells: implications for IGF-II mitogenic signaling

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2875253

28 November 2018

Adrenocortical carcinomas: surgical trends and results of a 253-patient series from the French Association of Endocrine Surgeons study group

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2875253

28 November 2018

Type I IGF receptor and acquired tamoxifen resistance in oestrogen-responsive human breast cancer cells.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2875253

28 November 2018

Clinical significance of insulin-like growth factor-binding protein-3 expression in stage I non-small cell lung cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/19649631

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Insulin-like growth factor (IGF)-I, IGF-II and IGF type I receptor (IGFR-I) expression in prostatic cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/19649631

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effect of acute administration of insulin-like growth factor I in patients with Laron-type dwarfism

1 reference

https://pubmed.ncbi.nlm.nih.gov/19649631

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Increased expression of insulin-like growth factor i is associated with Ara-C resistance in leukemia

1 reference

https://pubmed.ncbi.nlm.nih.gov/19649631

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Impact of IGF-1R/EGFR cross-talks on hepatoma cell sensitivity to gefitinib

1 reference

https://pubmed.ncbi.nlm.nih.gov/19649631

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Gene expression profiling of childhood adrenocortical tumors

1 reference

https://pubmed.ncbi.nlm.nih.gov/19649631

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Expression of a dominant-negative mutant human insulin receptor in the muscle of transgenic mice

1 reference

https://pubmed.ncbi.nlm.nih.gov/19649631

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Seminars in medicine of the Beth Israel Deaconess Medical Center. Insulin-like growth factors

1 reference

https://pubmed.ncbi.nlm.nih.gov/19649631

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Insulin-like growth factor receptors in normal and tumorous adult human adrenocortical glands

1 reference

https://pubmed.ncbi.nlm.nih.gov/19649631

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Circulating concentrations of insulin-like growth factor I and risk of breast cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/19649631

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A muscle-specific insulin receptor knockout exhibits features of the metabolic syndrome of NIDDM without altering glucose tolerance

1 reference

https://pubmed.ncbi.nlm.nih.gov/19649631

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Adrenocortical carcinoma

1 reference

https://api.crossref.org/works/10.1007%2FS00280-009-1083-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1007/S00280-009-1083-9

1 reference

Consolidated OpenCitations Corpus – April 2017

OpenCitations bibliographic resource ID

Dimensions Publication ID

0 references

OpenCitations bibliographic resource ID

1 reference

Consolidated OpenCitations Corpus – April 2017

OpenCitations bibliographic resource ID

PMC publication ID

1 reference

Consolidated OpenCitations Corpus – April 2017

OpenCitations bibliographic resource ID

PubMed publication ID

1 reference

Consolidated OpenCitations Corpus – April 2017

OpenCitations bibliographic resource ID

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q24607285&oldid=2176818278"